1. OC-0293 Early detection of chemo and RT-related heart toxicity in lymphoma patients: The CARDIOCARE Project. (May 2022) Authors: Levis, M.; Botto, B.; Andreis, A.; Gastino, A.; Blasi, L.; Bartoncini, S.; Giorgi, M.; Fava, A.; Cavallo, F.; Ferrero, S.; Boccomini, C.; Orsucci, L.; Ricardi, U. Journal: Radiotherapy and oncology Issue: Volume 170(2022)Supplement 1 Page Start: S255 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. OC-0925 Early adjuvant RT as a predictor of improved outcomes in patients with grade II and III meningiomas. (May 2022) Authors: Cuffini, E.M.; Casale, C.; Mantovani, C.; Gastino, A.; Lo Zito, B.; Blasi, L.; Bongiovanni, D.; Orlandi, E.; Cerrato, M.; Vella, A.; Leardi, S.; Chiofalo, V.; Cavallin, C.; Iorio, G.C.; Ricardi, U.; Levis, M. Journal: Radiotherapy and oncology Issue: Volume 170(2022)Supplement 1 Page Start: S816 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. PD-0672 Cardiac toxicity predicts mortality in NSCLC patients: interim analysis of the LUNG-HEART Study. (May 2022) Authors: Cerrato, M.; Badellino, S.; Menegatti, F.; Bonavero, I.; Grossi, C.; Lo Zito, B.; Orlandi, E.; Gastino, A.; Cuffini, E.M.; Blasi, L.; Mantovani, C.; Parise, R.; Ricardi, U.; Levis, M. Journal: Radiotherapy and oncology Issue: Volume 170(2022)Supplement 1 Page Start: S607 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Trajectory control algorithms for the de-orbiting and Re-entry of the MISTRAL satellite. (February 2023) Authors: Nocerino, A.; Notaro, I.; Morani, G.; Poderico, M.; D'Amato, E.; Blasi, L.; Fedele, A.; Fortezza, R.; Grassi, M.; Mattei, M. Journal: Acta astronautica Issue: Volume 203(2023) Page Start: 392 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Fibrous scaffolds fabricated by emulsion electrospinning: from hosting capacity to in vivo biocompatibility. Issue 17 (18th April 2016) Authors: Spano, F.; Quarta, A.; Martelli, C.; Ottobrini, L.; Rossi, R. M.; Gigli, G.; Blasi, L. Journal: Nanoscale Issue: Volume 8:Issue 17(2016) Page Start: 9293 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Efficacy and safety of Everolimus and Exemestane in hormone-receptor positive (HR+) human-epidermal-growth-factor negative (HER2−) advanced breast cancer patients: New insights beyond clinical trials. The EVA study. (October 2017) Authors: Alù, M.; Ancona, C.; Andreis, D.; Bajardi, E.; Benedetto, C.; Berardi, R.; Bordin, E.; Butti, C.; Capri, G.; Cicchiello, F.; Cocciolone, V.; Dester, M.; D'Onofrio, L.; Febbraro, A.; Ferrarini, I.; Fotia, V.; Gervasi, E.; Guaitoli, G.; Licata, L.; Liscia, N. Journal: Breast Issue: Volume 35(2017) Page Start: 115 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗